WSU's $80M Pharma and Biomed Building to Emphasize PGx, Expand Omics Capacity | GenomeWeb

NEW YORK (GenomeWeb News) – Washington State University today will officially open a new Pharmaceutical and Biomedical Sciences building, a $78.6 million facility that will house integrated drug, pharmacogenomics, genomics, imaging, and proteomics research programs and core labs.

The 125,000 square-foot facility in Spokane will also house the College of Pharmacy and will be home to much of the university's biomedical research programs, including resources and staff that are in the process of relocating to the building from WSU's campus in Pullman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.